Elanco provided 25 kilograms of MPL for use in dogs only. They couldn't have made much of a dent in that.
The new batch of MPL currently in manufacture is for upcoming human trials (MND, COVID & cancer).
Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints, page-50
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
-0.005(2.70%) |
Mkt cap ! $87.55M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 18.0¢ | $29.40K | 163.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 531103 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 18824 | 4 |
View Market Depth
| Last trade - 11.28am 04/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |